Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Engineering chromosomal rearrangements in mice

Key Points

  • Strategies have recently been developed that allow defined chromosomal rearrangements to be introduced into the mouse genome by engineering them in embryonic stem (ES) cells using the Cre/loxP site-specific recombination system. These rearrangements include chromosomal deletions, duplications, inversions and translocations.

  • Using these strategies, mouse models that accurately recapitulate human chromosomal rearrangements that cause disease have been generated. These include chromosomal translocations that are associated with leukaemia and chromosomal deletions, such as those that cause DiGeorge syndrome and Prader–Willi syndrome.

  • Chromosomal-engineering technology has also been used to generate genetic reagents for the functional analysis of the mouse genome. Deletion chromosomes that are marked by, for example, coat-colour markers, have been engineered to provide segmental haploidy in the mouse genome, and are used to detect recessive mutations that are generated in ethylnitrosourea (ENU) mutagenesis screens.

  • Mouse balancer chromosomes have also been developed using Cre/loxP technology, by tagging chromosomal inversions with recessive lethal mutations and coat-colour markers, for use in ENU mutagenesis screens. These chromosomes facilitate the detection of recessive mutations in the absence of genotypic analysis and allow recessive lethal mutations to be maintained.

  • Although the applications of chromosomal engineering technologies are still in their infancy, they are likely to become invaluable for mapping genetic loci, such as quantitative trait loci, in the future. Marked deletions and balancer chromosomes will also continue to gain importance in large-scale, recessive genetic screens in mice and will significantly contribute to the functional annotation of the mouse genome.

Abstract

The combination of gene-targeting techniques in mouse embryonic stem cells and the Cre/loxP site-specific recombination system has resulted in the emergence of chromosomal-engineering technology in mice. This advance has opened up new opportunities for modelling human diseases that are associated with chromosomal rearrangements. It has also led to the generation of visibly marked deletions and balancer chromosomes in mice, which provide essential reagents for maximizing the efficiency of large-scale mutagenesis efforts and which will accelerate the functional annotation of mammalian genomes, including the human genome.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: A general strategy for chromosomal engineering in mice.
Figure 2: Gene targeting in embryonic stem cells.
Figure 3: Engineering a deletion and/or a duplication in embryonic stem cells.
Figure 4: Engineering an inversion in embryonic stem cells.
Figure 5: Nested chromosomal deletions induced with a retroviral vector.
Figure 6: Engineering chromosomal translocations.
Figure 7: A mouse balancer chromosome and its use in ENU mutagenesis screens.

Similar content being viewed by others

References

  1. Epstein, C. J. The Consequences of Chromosome Imbalance: Principles, Mechanism and Models (Cambridge Univ. Press, Cambridge, UK, 1986).

    Book  Google Scholar 

  2. Shaffer, L. G. & Lupski, J. R. Molecular mechanisms for constitutional chromosomal rearrangements in humans. Annu. Rev. Genet. 34, 297–329 (2000).

    Article  CAS  Google Scholar 

  3. Rabbitts, T. H. Chromosomal translocations in human cancer. Nature 372, 143–149 (1994).

    Article  CAS  Google Scholar 

  4. Russell, W. L. X-ray induced mutations in mice. Cold Spring Harbor Symp. Quant. Biol. 16, 327–336 (1951).

    Article  CAS  Google Scholar 

  5. Russell, L. B. et al. Chlorambucil effectively induces deletion mutations in mouse germ cells. Proc. Natl Acad. Sci. USA 86, 3704–3708 (1989).

    Article  CAS  Google Scholar 

  6. Davisson, M. T., Schmidt, C. & Akeson, E. C. Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome. Prog. Clin. Biol. Res. 360, 263–280 (1990).

    CAS  PubMed  Google Scholar 

  7. Roderick, T. in Utilization of Mammalian Specific-Locus Studies in Hazard Evaluation and Estimation of Genetic Risk (ed. de-Serres, F. & Sheridan, W.) 135–167 (Plenum, New York, 1983).

    Book  Google Scholar 

  8. Stubbs, L., Carver, E. A., Cacheiro, N. L., Shelby, M. & Generoso, W. Generation and characterization of heritable reciprocal translocations in mice. Methods 13, 397–408 (1997).

    Article  CAS  Google Scholar 

  9. Reeves, R. H. et al. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nature Genet. 11, 177–184 (1995).

    Article  CAS  Google Scholar 

  10. Rinchik, E. M. & Russell, L. B. in Genome Analysis Vol. I (ed. Davies, K. & Tilghman, S.) 121–158 (CSH Laboratory Press, Cold Spring Harbor, 1990).

    Google Scholar 

  11. Rinchik, E. M. Developing genetic reagants to facilitate recovery, analysis, and maintenance of mouse mutations. Mamm. Genome 11, 489–499 (2000).

    Article  CAS  Google Scholar 

  12. Ramirez-Solis, R., Liu, P. & Bradley, A. Chromosome engineering in mice. Nature 378, 720–724 (1995).This is the first paper to describe the generation of megabase genomic rearrangements in mice by using chromosomal engineering technology.

    Article  CAS  Google Scholar 

  13. Lindsay, E. A. et al. Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 401, 379–383 (1999).

    CAS  PubMed  Google Scholar 

  14. Tsai, T. F., Jiang, Y. H., Bressler, J., Armstrong, D. & Beaudet, A. L. Paternal deletion from Snrpn to Ube3a in the mouse causes hypotonia, growth retardation and partial lethality and provides evidence for a gene contributing to Prader–Willi syndrome. Hum. Mol. Genet. 8, 1357–1364 (1999).

    Article  CAS  Google Scholar 

  15. Buchholz, F., Refaeli, Y., Trumpp, A. & Bishop, J. M. Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse. EMBO Rep. 1, 133–139 (2000).

    Article  CAS  Google Scholar 

  16. Collins, E. C., Pannell, R., Simpson, E. M., Forster, A. & Rabbitts, T. H. Inter-chromosomal recombination of Mll and Af9 genes mediated by creloxP in mouse development. EMBO Rep. 1, 127–132 (2000).

    Article  CAS  Google Scholar 

  17. Merscher, S. et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104, 619–629 (2001).

    Article  CAS  Google Scholar 

  18. Lindsay, E. A. et al. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410, 97–101 (2001).

    Article  CAS  Google Scholar 

  19. Zheng, B., Mills, A. A. & Bradley, A. A system for rapid generation of coat color-tagged knockouts and defined chromosomal rearrangements in mice. Nucleic Acids Res. 27, 2354–2360 (1999).

    Article  CAS  Google Scholar 

  20. Zheng, B. et al. Engineering a mouse balancer chromosome. Nature Genet. 22, 375–378 (1999).This study describes the first mouse balancer chromosome to be developed using chromosomal engineering techniques.

    Article  CAS  Google Scholar 

  21. Justice, M. J. in Mouse Genetics and Transgenics (eds Jackson, I. J. & Abbott, C. M.) 185–215 (Oxford Univ. Press, New York, 2000).

    Google Scholar 

  22. Dietrich, W. F. et al. A comprehensive genetic map of the mouse genome. Nature 380, 149–152 (1996); erratum 381, 172 (1996).

    Article  CAS  Google Scholar 

  23. Flaherty, L. & Herron, B. The new kid on the block — a whole genome mouse radiation hybrid panel. Mamm. Genome 9, 417–418 (1998).

    Article  CAS  Google Scholar 

  24. Li, Z. W. et al. Generation of mice with a 200-kb amyloid precursor protein gene deletion by Cre recombinase-mediated site-specific recombination in embryonic stem cells. Proc. Natl Acad. Sci. USA 93, 6158–6162 (1996); erratum 93, 12052 (1996).

    Article  CAS  Google Scholar 

  25. Zheng, B., Sage, M., Sheppeard, E. A., Jurecic, V. & Bradley, A. Engineering mouse chromosomes with Cre–loxP: range, efficiency, and somatic applications. Mol. Cell. Biol. 20, 648–655 (2000).

    Article  CAS  Google Scholar 

  26. Liu, P., Zhang, H., McLellan, A., Vogel, H. & Bradley, A. Embryonic lethality and tumorigenesis caused by segmental aneuploidy on mouse chromosome 11. Genetics 150, 1155–1168 (1998).

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Ramirez-Solis, R., Davis, A. C. & Bradley, A. in Guide to Techniques in Mouse Development Vol. 225 (eds Wassarman, P. M. & DePamphilis, M. L.) 855–878 (Academic Press, Inc., San Diego, 1993).

    Book  Google Scholar 

  28. Bradley, A., Zheng, B. & Liu, P. Thirteen years of manipulating the mouse genome: a personal history. Int. J. Dev. Biol. 42, 943–950 (1998).

    CAS  PubMed  Google Scholar 

  29. O'Gorman, S., Dagenais, N. A., Qian, M. & Marchuk, Y. Protamine–Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc. Natl Acad. Sci. USA 94, 14602–14607 (1997).

    Article  CAS  Google Scholar 

  30. Schlake, T. et al. Predetermined chromosomal deletion encompassing the Nf-1 gene. Oncogene 18, 6078–6082 (1999).

    Article  CAS  Google Scholar 

  31. Zhu, Y. et al. Genomic interval engineering of mice identifies a novel modulator of triglyceride production. Proc. Natl Acad. Sci. USA 97, 1137–1142 (2000).

    Article  CAS  Google Scholar 

  32. Madsen, L. et al. Mice lacking all conventional MHC class II genes. Proc. Natl Acad. Sci. USA 96, 10338–10343 (1999).

    Article  CAS  Google Scholar 

  33. Su, H., Wang, X. & Bradley, A. Nested chromosomal deletions induced with retroviral vectors in mice. Nature Genet. 24, 92–95 (2000).This paper described a strategy for efficiently generating nested chromosomal deletions using a recombinant retrovirus. This approach also facilitates the identification of nested end points.

    Article  CAS  Google Scholar 

  34. LePage, D. F., Church, D. M., Millie, E., Hassold, T. J. & Conlon, R. A. Rapid generation of nested chromosomal deletions on mouse chromosome. Part 2. Proc. Natl Acad. Sci. USA 97, 10471–10476 (2000).

    Article  CAS  Google Scholar 

  35. You, Y. et al. Chromosomal deletion complexes in mice by radiation of embryonic stem cells. Nature Genet. 15, 285–288 (1997).

    Article  CAS  Google Scholar 

  36. Thomas, J. W., LaMantia, C. & Magnuson, T. X-ray-induced mutations in mouse embryonic stem cells. Proc. Natl Acad. Sci. USA 95, 1114–1119 (1998).

    Article  CAS  Google Scholar 

  37. Kushi, A. et al. Generation of mutant mice with large chromosomal deletion by use of irradiated ES cells — analysis of large deletion around hprt locus of ES cell. Mamm. Genome 9, 269–273 (1998).

    Article  CAS  Google Scholar 

  38. Smith, A. J. et al. A site-directed chromosomal translocation induced in embryonic stem cells by Cre–loxP recombination. Nature Genet. 9, 376–385 (1995); erratum 12, 110 (1996).

    Article  CAS  Google Scholar 

  39. Van Deursen, J., Fornerod, M., Van Rees, B. & Grosveld, G. Cre-mediated site-specific translocation between nonhomologous mouse chromosomes. Proc. Natl Acad. Sci. USA 92, 7376–7380 (1995).References 38 and 39 introduce the use of targeted Cre/ loxP strategies for generating chromosomal translocations in mouse embryonic stem cells.

    Article  CAS  Google Scholar 

  40. Lyon, M. F. & Meredith, R. Autosomal translocations causing male sterility and viable aneuploidy in the mouse. Cytogenetics 5, 335–354 (1966).

    Article  CAS  Google Scholar 

  41. Scambler, P. J. The 22q11 deletion syndromes. Hum. Mol. Genet. 9, 2421–2426 (2000).

    Article  CAS  Google Scholar 

  42. Dunham, I. et al. The DNA sequence of human chromosome 22. Nature 402, 489–495 (1999); erratum 404, 904 (2000).

    Article  CAS  Google Scholar 

  43. Herault, Y., Rassoulzadegan, M., Cuzin, F. & Duboule, D. Engineering chromosomes in mice through targeted meiotic recombination (TAMERE). Nature Genet. 20, 381–384 (1998).

    Article  CAS  Google Scholar 

  44. Matsusaka, T. et al. Dual renin gene targeting by Cre-mediated interchromosomal recombination. Genomics 64, 127–131 (2000).

    Article  CAS  Google Scholar 

  45. Antoch, M. P. et al. Functional identification of the mouse circadian Clock gene by transgenic BAC rescue. Cell 89, 655–667 (1997).

    Article  CAS  Google Scholar 

  46. Hejna, J. A. et al. Functional complementation by electroporation of human BACs into mammalian fibroblast cells. Nucleic Acids Res. 26, 1124–1125 (1998).

    Article  CAS  Google Scholar 

  47. Liu, P. et al. Requirement for Wnt3 in vertebrate axis formation. Nature Genet. 22, 361–365 (1999).

    Article  CAS  Google Scholar 

  48. Mackay, T. F. Quantitative trait loci in Drosophila. Nature Rev. Genet. 2, 11–20 (2001).

    Article  CAS  Google Scholar 

  49. Reeves, R. H., Baxter, L. L. & Richtsmeier, J. T. Too much of a good thing: mechanisms of gene action in Down syndrome. Trends Genet. 17, 83–88 (2001).

    Article  CAS  Google Scholar 

  50. Sago, H. et al. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc. Natl Acad. Sci. USA 95, 6256–6261 (1998).

    Article  CAS  Google Scholar 

  51. Hoess, R. H. & Abremski, K. in Nucleic Acids and Molecular Biology Vol. 4 (eds Eckstein, F. & Lilley, D. M. J.) 99–109 (Springer, Berlin and Heidelberg, 1990).

    Book  Google Scholar 

  52. Sadowski, P. D. Site-specific genetic recombination: hops, flips, and flops. FASEB J. 7, 760–767 (1993).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank M. Wentland for comments on this manuscript and A. Pao for assistance in preparing the figures. Work in the authors' lab is supported by the National Institutes of Health, the Howard Hughes Medical Institute and the Wellcome Trust.

Author information

Authors and Affiliations

Authors

Supplementary information

Related links

Related links

DATABASES

LocusLink 

AF9

AML1

ETO

MLL

 MGI 

albino

Hprt

Mll

pink-eyed dilution

Trp53

Wnt3

 OMIM 

DiGeorge syndrome

Prader–Willi syndrome

Smith–Magenis syndrome

trisomy 21

FURTHER INFORMATION

Cell line Request Form

Chromosome 11 deletion map

Chromosome 11 ENU mutagenesis programme

Genetic and physical maps of the mouse genome

NCBI's mouse genome sequencing page

STS Physical Map of the Mouse

t(8;21)(q22:q22)

t(9;11)(p22;q23)

The Bradley Lab Protocols

The Sanger Centre

Glossary

SEGMENTAL HAPLOIDY

When a diploid organism is haploid for a certain chromosomal region after its deletion or loss.

BALANCER CHROMOSOME

A chromosome with one or more inverted segments that suppress recombination. They are used as genetic tools because they allow lethal mutations to be maintained without selection.

CROSSING OVER

The exchange of genetic material between two homologous chromosomes.

BLASTOCYST

A preimplantation embryo that contains a fluid-filled cavity called a blastocoel.

POSITIVE SELECTION

When a specific chemical is added to a culture medium, the cells that express a positive selectable marker gene, such as the neomycin or puromycin resistance genes, survive and are selected for.

HPRT MINIGENE

(Hypoxanthine phosphoribosyl transferase gene). This is divided into two complementary, but non-functional, fragments: 5′Hprt contains exons 1–2 and 3′Hprt contains the remaining exons, 3–9. Each Hprt fragment is linked to a loxP site, and Cre-mediated recombination unites the 5′ and 3′ cassettes, and restores Hprt activity, which is required for purine biosynthesis and allows desired recombination events to be selected for in HAT (hypoxanthine, aminopterin and thymidine) medium.

ACENTRIC

A chromosome or chromatid without a centromere.

DICENTRIC

A chromatid or a chromosome that has two centromeres.

K14AGOUTI

A transgene in which the agouti gene is under the control of the keratin 14 promoter. Its expression produces a yellowish coat colour in mice.

TYROSINASE

Tyrosinase is required for melanin biosynthesis, and the expression of its gene leads to pigment production, and is therefore used as a coat-colour marker.

HSVTK

The herpes simplex virus thymidine kinase (HSVtk) is essential for thymidine nucleotide biosynthesis through a salvage pathway and is often used as a negative selectable marker in gene targeting.

NEGATIVE SELECTABLE MARKER

A negative selectable marker gene, such as HSVtk, allows cells that express it to be killed when a specific chemical is added to a culture medium, whereas cells that no longer express the marker gene survive.

HAPLOINSUFFICIENCY

A phenotype that arises in diploid organisms owing to the loss of one functional copy of a gene.

HYBRID ES-CELL LINE

An embryonic stem (ES) cell line isolated from F1 hybrid embryos, such as from crosses between the strains C57BL/6-Tyrc1Brd × 129S7 or 129S1 × CAST/Ei. These lines facilitate simple sequence length polymorphism analysis.

ENU

(N-ethyl-N-nitrosourea). A potent mutagen that primarily generates single-base-pair mutations in mouse spermatogonia germ cells.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, Y., Bradley, A. Engineering chromosomal rearrangements in mice. Nat Rev Genet 2, 780–790 (2001). https://doi.org/10.1038/35093564

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/35093564

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing